Related Experiment Video
Updated: Jul 4, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Novel molecular-targeted therapeutics for the treatment of cancer
1First Department of Internal Medicine, Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo, 060-0061, Japan.
Abstract:
Recently, intensive laboratory and preclinical studies have identified and validated therapeutic molecular targets in cancer, particularly the receptor tyrosine kinases, the intracellular pathways, and the genetic and epigenetic alterations, resulting in an unprecedented surge of novel, targeted therapies and therapeutic regimens. There are currently over 30 new agents being tested in the treatment of solid tumors as well as hematologic malignancies. Many of these are novel, targeted agents that have demonstrated significant efficacy and prolonged survival. Here, we discuss the current understanding of the mechanisms of action of novel molecular targeted cancer therapies being tested in the preclinical and clinical settings, including agents that act directly on the cell surface receptors, intracellular signaling pathways, and cell maintenance processes.
Insights
Novel targeted cancer therapies are emerging, with over 30 agents in development. These therapies target molecular pathways and genetic alterations, showing significant efficacy in treating solid tumors and hematologic malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Intensive research has identified key molecular targets in cancer, including receptor tyrosine kinases, intracellular pathways, and genetic/epigenetic alterations.
- This has led to a significant increase in the development of novel, targeted cancer therapies and treatment regimens.
- Over 30 new agents are currently undergoing testing for solid tumors and hematologic malignancies.
Purpose of the Study:
- To discuss the current understanding of the mechanisms of action for novel molecular targeted cancer therapies.
- To review agents being investigated in preclinical and clinical settings.
- To highlight therapies targeting cell surface receptors, intracellular signaling, and cell maintenance processes.
Main Methods:
- Review of recent laboratory and preclinical studies.
- Analysis of ongoing clinical trials for novel targeted agents.
- Discussion of mechanisms of action for various targeted therapies.
Main Results:
- Identification and validation of numerous therapeutic molecular targets in cancer.
- Development of over 30 novel targeted agents showing significant efficacy.
- Demonstrated prolonged survival in patients treated with these novel agents.
Conclusions:
- Novel molecular targeted therapies represent a promising advancement in cancer treatment.
- These therapies target specific molecular pathways and alterations, leading to improved patient outcomes.
- Ongoing research continues to expand the landscape of targeted cancer therapeutics.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
